Anika Therapeutics Inc. (ANIK) Fundamentals

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of revenue from the United States.
SHARE INFORMATION
Market Cap$ 327,673,166
Shares Outstanding14,543,860
Float10,550,803
Percent Float72.54%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 147,794,000
Latest Fiscal EPS$ 0.29
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions344
Institutional Holdings Date2022-05-31
Institutional Bought Previous 3 Months2,074,949
Institutional Holdings Percent92.7%
Institutional Sold Previous 3 Months1,811,927
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months472,621
Insider Holdings Percent5.3
Insider Sold Previous 3 Months25,713
Insider Shares Owned766,586
TRADING INFO
52 Week High$ 45.81
52 Week Low$ 19.95
52 Week High Change$ -49.63
21 Day Moving Average$ 21.9148
21 Day Extended Moving Average$ 22.0459
50 Day Moving Average$ 21.9334
50 Day Extended Moving Average$ 22.7521
200 Day Moving Average$ 31.9247
200 Day Extended Moving Average$ 29.6328
10 Day Average Volume177,716
20 Day Average Volume146,426
30 Day Average Volume127,350
50 Day Average Volume117,529
Alpha-0.014956
Beta1.1103
Standard Deviation0.133890
R20.154214
7 Day Price Change$ 0.45
7 Day Percent Change2.04%
21 Day Price Change$ 0.19
21 Day Percent Change0.85%
30 Day Price Change$ 1.50
30 Day Percent Change7.13%
Month to Date Price Change$ 0.79
Month to Date Percent Change3.63%
Quarter to Date Price Change$ -2.58
Quarter to Date Percent Change-10.27%
180 Day Price Change$ -15.46
180 Day Percent Change-40.69%
200 Day Price Change$ -16.72
200 Day Percent Change-42.6%
Year to Date Price Change$ -13.30
Year to Date Percent Change-37.12%

Anika Therapeutics Inc. (ANIK) Key Ratios

PROFITABILITY
EBIT Margin-12.3%
EBITDA Margin-2.7%
Pre-Tax Profit Margin9.3%
Profit Margin Count-1.21%
Gross Margin55.8%
Profit Margin TOT-1.21%
INCOME STATEMENTS
Revenue$ 150,195,000
Revenue Per Share$ 10.327
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.70
Total Debt To Equity0.10
Int Coverage0.00
Current Ratio6.10
Leverage Ratio1.20
Quick Ratio4.40
Long Term Debt To Capital0.06
VALUATION MEASURES
PE Ratio-204.80
Enterprise Value$ 257,818,165
Price to Sales2.1817
Price to Free Cash117.80
PE High Last 5 Years59.20
Price To Book1.20
Price To Cash Flow36.80
PE Low Last 5 Years-19.10
Price to Tangible Book1.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover5.70
Invoice Turnover1.80
Assets Turnover0.40
Return Assets-0.48
Return on Equity-0.60
Return on Capital-0.54

Anika Therapeutics Inc. (ANIK) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorDeloitte & Touche LLP
CEOCheryl R. Blanchard
Emplyoees297
Last AuditUQ
CIK0000898437
IndustryMedical Devices & Instruments
SectorHealthcare
NAICSIn-Vitro Diagnostic Substance Manufacturing(325413)
CONTACT INFO
Address32 Wiggins Avenue
Bedford, MA 1730
Websitehttps://www.anika.com
Facsimile+1 781 305-9720
Telephone+1 781 457-9000
Emailinvestorrelations@anikatherapeutics.com
Your Recent History
NASDAQ
ANIK
Anika Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220628 06:40:19